Overview of 119

119 is a medical device/med tech startup focused on improving emergency care for individuals with chronic conditions, disabilities, developmental differences and aging-related challenges. Our mission is to reduce unnecessary 911 calls and ensure timely, accurate responses during medical emergencies through a patented, real-time communication tool. We are currently navigating FDA regulations and testing the solution.

Our Ask

119’s main ask is to raise $1.5M in funding to support product development and move through the FDA regulatory process. We are also seeking strategic partnerships with healthcare organizations and clinicians to accelerate adoption and bring 119 to market. We would specifically like to collaborate at this juncture with neurologists/epileptologists, pulmonologists and endocrinologists as they pertain to our beachhead conditions of asthma, diabetes and epilepsy.

Product or Service

119 is a patented mobile app that guides bystanders with personalized, step-by-step guidance tailored to the user’s specific conditions and preferences. Built for people with chronic illnesses, disabilities, or aging-related conditions, it empowers users to manage recurring or misunderstood health events safely only relying on 911 when needed. The app integrates medical info, emergency contacts, GPS, and condition-specific prompts to improve outcomes and preserve autonomy. Unlike traditional medical alert systems that default to summoning emergency services, 119 will enable tailored care when professional help isn’t needed.

Company Impact

119’s impact lies in its ability to empower bystanders with patented, real-time and step-by-step guidance during medical emergencies for individuals who often experience recurring and misunderstood health events. By reducing unnecessary 911 calls and improving emergency response, 119 enhances health outcomes and promotes independence for vulnerable communities. Its innovation comes from the personalized emergency guidance system and specialized modules tailored for conditions like asthma, diabetes, and IDD, ensuring that every individual receives appropriate care in critical moments. In one Ohio case study, unwanted 911 calls dropped from 4/week to 1 in 16 weeks. The app’s digestible audio guidance engages bystanders more effectively than bracelets or medical ID cards – turning panic into purposeful action and protecting users’ dignity and autonomy. 119 will reduce unnecessary emergency calls, improves outcomes and promotes independence.

Primary Audience

Primary audience/beneficiaries:

– People with chronic illnesses, disabilities, or age-related conditions – 119 helps them stay safe during public medical events by ensuring appropriate support.

– Bystanders – Get real-time, step-by-step guidance to respond effectively in emergencies.

– First responders – Access personalized context to improve care and avoid unnecessary escalation.

– Family members and caregivers – Gain peace of mind knowing their loved ones are supported, even when alone.

Partnership Opportunity

Potential areas for collaboration and partnership:
– Healthcare systems and clinics – To integrate 119 into care plans and extend patient support into public spaces.

– Disability and chronic illness advocacy groups – For co-design, outreach, and trust-building in target communities.

– Public safety and EMS organizations – To align guidance with emergency protocols and train responders.

– Schools, transit, and public venues – For on-site implementation to protect high-risk individuals in shared spaces.

– Technology partners – To enhance accessibility, scale deployment, and maintain secure infrastructure.

– Insurers and government agencies – For coverage, public health integration, and policy alignment.

Funding Needs

119’s main ask is to raise $1.5M in funding to support product development and move through the FDA regulatory process. We are also seeking strategic partnerships with healthcare organizations and clinicians to accelerate adoption and bring 119 to market. We would specifically like to collaborate at this juncture with neurologists/epileptologists, pulmonologists and endocrinologists as they pertain to our beachhead conditions of asthma, diabetes and epilepsy.

Get More Info

Name
Email

FOR DONOR ADVISED FUND & WIRE INSTRUCTIONS PLEASE REACH OUT TO: pkent@disabledlifefoundation.org

disAbled Life Foundation (Montcalm Social Enterprise) is a fiscally sponsored program of Legacy Global Programs, a 501(c)3 organization, EIN: 20-8099462

FOR DONOR ADVISED FUND & WIRE INSTRUCTIONS PLEASE REACH OUT TO: pkent@disabledlifefoundation.org

disAbled Life Foundation (Montcalm Social Enterprise) is a fiscally sponsored program of Legacy Global Programs, a 501(c)3 organization, EIN: 20-8099462

Name
Email